To this end, we then quantified the intracellular ROS level and HIF-1 transcriptional activity of CRC cells upon oxLDL treatment through DCFH-DA staining and luciferase reporter assays, respectively. The gene discussed is HIF1A; the disease is colorectal carcinoma.